Literature DB >> 26184764

Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism.

Po-Yu Tseng1, Wu-Chang Yang, Chih-Yu Yang, Der-Cherng Tarng.   

Abstract

BACKGROUND/AIMS: Hyperparathyroidism (HPT) is a common complication of chronic kidney disease and contributes to hypertension and cardiovascular risks. Successful kidney transplantation corrects abnormal mineral metabolism, but persistent HPT is still observed in up to 25% of patients one year after transplantation despite renal function improvement. The purpose of this study was to examine the long-term effects of parathyroidectomy (PTX) on blood pressure (BP) and graft function in patients with persistent post-transplant HPT.
METHODS: This is a retrospective study of renal allograft recipients at a single institute. Records from all the patients who received kidney transplantation at the Taipei Veterans General Hospital between 2004 and 2012 were reviewed and enrolled 19 patients who underwent PTX for persistent post-transplant HPT. Preoperative and postoperative clinical and biochemical data were compared. Matched controls (n = 19) in the corresponding time span were enrolled for graft function comparisons.
RESULTS: The mean systolic BP (127.7 ± 14.3 to 119.5 ± 12.7 mmHg, p = 0.028, 1 year after PTX; 127.7 ± 14.3 to 117 ± 12.4 mmHg, p = 0.007, 2 years after PTX) and pulse pressure (PP) (51.3 ± 10.7 to 44.3 ± 11.6, p = 0.019 1 year after PTX; 51.3 ± 10.7 to 44.9 ± 12.5 mmHg, p = 0.028, 2 years after PTX) reduced significantly at 1 year and 2 years of follow-up. However, no significant change of diastolic BP was observed. The improvement of SBP, DBP and PP was not correlated with the reduction of serum calcium level 1 year after PTX. The estimated glomerular filtration rate decreased significantly from 74.0 ± 20.5 mL/min/1.73m(2) preoperatively to 68.2 ± 24.8 mL/min/1.73 m(2) 12 months after PTX but recovered at 15 months and lasted to 2 years after PTX. The all-cause hospitalization rate 1 year after PTX tended to be higher than that 1 year before PTX (105.3 versus 47.4 per 100 patient-years; RR, 2.22; 95 % CI: 0.97-5.54), but there was no significant difference between them.
CONCLUSIONS: Our study demonstrated systolic BP and PP reduced 2 years after PTX and there was no significant difference between the peri-operative all-cause hospitalization rates. In addition, kidney allograft function impaired temporarily 12 months after PTX, but recovered 15 months after PTX.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26184764     DOI: 10.1159/000368514

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

Review 1.  Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.

Authors:  Kerstin Lorenz; Detlef K Bartsch; Juan J Sancho; Sebastien Guigard; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2015-10-02       Impact factor: 3.445

2.  Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study.

Authors:  Samuel Frey; Thomas Goronflot; Claire Blanchard; Clarisse Kerleau; Pierre-Antoine Gourraud; Matthieu Wargny; Cécile Caillard; Maryvonne Hourmant; Lucile Figueres; Éric Mirallié
Journal:  Langenbecks Arch Surg       Date:  2022-05-21       Impact factor: 2.895

Review 3.  Metabolic Disorders with Kidney Transplant.

Authors:  Elizabeth Cohen; Maria Korah; Glenda Callender; Renata Belfort de Aguiar; Danielle Haakinson
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-13       Impact factor: 8.237

4.  Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes.

Authors:  Aarti Mathur; Whitney Sutton; JiYoon B Ahn; Jason D Prescott; Martha A Zeiger; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Transplantation       Date:  2021-12-01       Impact factor: 5.385

5.  Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.

Authors:  Lena Berchtold; Belen Ponte; Solange Moll; Karine Hadaya; Olivia Seyde; Matthias Bachtler; Jean-Paul Vallée; Pierre-Yves Martin; Andreas Pasch; Sophie de Seigneux
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

Review 6.  A roadmap to parathyroidectomy for kidney transplant candidates.

Authors:  Giuseppe Cianciolo; Francesco Tondolo; Simona Barbuto; Andrea Angelini; Francesca Ferrara; Francesca Iacovella; Concettina Raimondi; Gaetano La Manna; Carla Serra; Chiara De Molo; Ottavio Cavicchi; Ottavio Piccin; Pasquale D'Alessio; Loredana De Pasquale; Giovanni Felisati; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  Clin Kidney J       Date:  2022-02-23

7.  Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients.

Authors:  Whitney Sutton; Xiaomeng Chen; Palak Patel; Shkala Karzai; Jason D Prescott; Dorry L Segev; Mara McAdams-DeMarco; Aarti Mathur
Journal:  Surgery       Date:  2021-07-12       Impact factor: 3.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.